IL293800B2 - Preparation of trifarotene and intermediates and polymorphs thereof - Google Patents
Preparation of trifarotene and intermediates and polymorphs thereofInfo
- Publication number
- IL293800B2 IL293800B2 IL293800A IL29380022A IL293800B2 IL 293800 B2 IL293800 B2 IL 293800B2 IL 293800 A IL293800 A IL 293800A IL 29380022 A IL29380022 A IL 29380022A IL 293800 B2 IL293800 B2 IL 293800B2
- Authority
- IL
- Israel
- Prior art keywords
- trifarotene
- group
- formula
- alkyl
- polymorph
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/402—1-aryl substituted, e.g. piretanide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962946943P | 2019-12-11 | 2019-12-11 | |
| PCT/US2020/064365 WO2021119351A1 (en) | 2019-12-11 | 2020-12-10 | Preparation of trifarotene and intermediates and polymorphs thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| IL293800A IL293800A (en) | 2022-08-01 |
| IL293800B1 IL293800B1 (en) | 2024-06-01 |
| IL293800B2 true IL293800B2 (en) | 2024-10-01 |
Family
ID=74141909
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL293800A IL293800B2 (en) | 2019-12-11 | 2020-12-10 | Preparation of trifarotene and intermediates and polymorphs thereof |
| IL312356A IL312356A (en) | 2019-12-11 | 2020-12-10 | Preparation of trifarotene and intermediates and polymorphs thereof |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL312356A IL312356A (en) | 2019-12-11 | 2020-12-10 | Preparation of trifarotene and intermediates and polymorphs thereof |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11691946B2 (https=) |
| EP (2) | EP4073035B1 (https=) |
| JP (3) | JP7281016B2 (https=) |
| CN (1) | CN114787129B (https=) |
| AU (2) | AU2020402049B2 (https=) |
| CA (1) | CA3161509A1 (https=) |
| ES (1) | ES3037292T3 (https=) |
| IL (2) | IL293800B2 (https=) |
| WO (1) | WO2021119351A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL293800B2 (en) * | 2019-12-11 | 2024-10-01 | Taro Pharma Ind | Preparation of trifarotene and intermediates and polymorphs thereof |
| CN117342993A (zh) * | 2022-07-05 | 2024-01-05 | 石家庄迪斯凯威医药科技有限公司 | 一种曲法罗汀盐及其药物组合物和用途 |
| CN115745913B (zh) * | 2022-09-16 | 2024-05-24 | 南京迈诺威医药科技有限公司 | 曲法罗汀多晶型及其制备方法 |
| JP2026507122A (ja) * | 2023-02-28 | 2026-02-27 | タロー・ファーマシューティカル・インダストリーズ・リミテッド | トリファロテンを調製する方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1248869A2 (en) * | 2000-01-07 | 2002-10-16 | Transform Pharmaceuticals, Inc. | High-throughput formation, identification, and analysis of diverse solid-forms |
| WO2004083335A2 (en) * | 2003-03-21 | 2004-09-30 | University Of Rochester | Glassy chiral-nematic liquid crystals and optical devices containing same |
| US8354427B2 (en) | 2004-06-24 | 2013-01-15 | Vertex Pharmaceutical Incorporated | Modulators of ATP-binding cassette transporters |
| DK1817301T3 (da) * | 2004-11-22 | 2012-02-27 | Lilly Co Eli | Forstærkere af glutamat-receptorer |
| PL1831149T3 (pl) * | 2004-12-23 | 2012-06-29 | Galderma Res & Dev | Nowe ligandy, które modulują receptory RAR, i ich zastosowanie w medycynie i kosmetyce |
| GB2426247A (en) | 2005-05-20 | 2006-11-22 | Arrow Int Ltd | Methods of preparing purine derivatives such as famciclovir |
| EP3475312B1 (en) * | 2016-06-23 | 2020-05-27 | Galderma S.A. | Cyclodextrin-grafted cross-linked hyaluronic acid complexed with active drug substances and uses thereof |
| IL293800B2 (en) * | 2019-12-11 | 2024-10-01 | Taro Pharma Ind | Preparation of trifarotene and intermediates and polymorphs thereof |
-
2020
- 2020-12-10 IL IL293800A patent/IL293800B2/en unknown
- 2020-12-10 JP JP2022534812A patent/JP7281016B2/ja active Active
- 2020-12-10 AU AU2020402049A patent/AU2020402049B2/en active Active
- 2020-12-10 EP EP20838774.6A patent/EP4073035B1/en active Active
- 2020-12-10 EP EP25166751.5A patent/EP4552691A3/en active Pending
- 2020-12-10 ES ES20838774T patent/ES3037292T3/es active Active
- 2020-12-10 IL IL312356A patent/IL312356A/en unknown
- 2020-12-10 CA CA3161509A patent/CA3161509A1/en active Pending
- 2020-12-10 CN CN202080085458.5A patent/CN114787129B/zh active Active
- 2020-12-10 WO PCT/US2020/064365 patent/WO2021119351A1/en not_active Ceased
- 2020-12-10 US US17/756,994 patent/US11691946B2/en active Active
-
2023
- 2023-05-12 JP JP2023079468A patent/JP2023100974A/ja active Pending
- 2023-05-12 US US18/316,742 patent/US20230278956A1/en active Pending
- 2023-09-01 AU AU2023222982A patent/AU2023222982B2/en active Active
-
2025
- 2025-11-07 JP JP2025188194A patent/JP2026016786A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2026016786A (ja) | 2026-02-03 |
| IL293800A (en) | 2022-08-01 |
| JP2022550632A (ja) | 2022-12-02 |
| EP4552691A3 (en) | 2025-09-10 |
| IL293800B1 (en) | 2024-06-01 |
| CA3161509A1 (en) | 2021-06-17 |
| WO2021119351A1 (en) | 2021-06-17 |
| US20230051259A1 (en) | 2023-02-16 |
| CN114787129B (zh) | 2025-07-04 |
| AU2023222982B2 (en) | 2025-01-02 |
| EP4073035B1 (en) | 2025-05-07 |
| NZ788464A (en) | 2024-07-05 |
| EP4073035A1 (en) | 2022-10-19 |
| US11691946B2 (en) | 2023-07-04 |
| IL312356A (en) | 2024-06-01 |
| JP7281016B2 (ja) | 2023-05-24 |
| JP2023100974A (ja) | 2023-07-19 |
| EP4552691A2 (en) | 2025-05-14 |
| AU2020402049B2 (en) | 2023-06-01 |
| CN114787129A (zh) | 2022-07-22 |
| AU2023222982A1 (en) | 2023-09-21 |
| US20230278956A1 (en) | 2023-09-07 |
| AU2020402049A1 (en) | 2022-06-09 |
| ES3037292T3 (en) | 2025-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL293800B2 (en) | Preparation of trifarotene and intermediates and polymorphs thereof | |
| IL268683B (en) | Processes for preparing ag-10, its intermediates, and salts thereof | |
| CN102947270B (zh) | 制备4-羟基吡啶的方法 | |
| IL298083A (en) | Solid forms of apol1 inhibitor and use thereof | |
| IL275272B (en) | Novel method for producing 5,5-disubstituted-4,5-dihydroisoxazole | |
| IL225808A (en) | Sesquihydrate of 1-{(2s)-2-amino-4-[2,4-bis(trifluoromethyl)-5,8-di-hydropyrido[3,4-d]pyrimidin-7(6h)-yl]-4-oxobutyl}-5,5-difluoro-piperidin-2-one tartrate, process for its preparation and pharmaceutical compositions comprising it for treating diabetes and obesity | |
| JP7630444B2 (ja) | Ｘｐｏ１阻害剤の調製プロセス及びｘｐｏ１阻害剤の調製に用いられる中間体 | |
| IL298694A (en) | Method for preparing 5-bromo-2-(3-chloro-pyridin-2-yl)-2H-pyrallose-3-carboxylic acid | |
| IL319883A (en) | Processes and intermediates for the preparation of cyclase-based geonalite fans | |
| IL319273A (en) | A series of bridged nitrogen-containing heterocyclic compounds and a method for their preparation | |
| IL322952A (en) | Methods for preparing triprotane | |
| IL297684A (en) | Processes for the preparation of a kinase inhibitor | |
| IL297521A (en) | Synthesis of sulfonamide intermediates | |
| CN106748888A (zh) | 一种西他列汀的中间体及其合成方法 | |
| IL272366B2 (en) | Adamantylmethylamine derivatives and their uses as a pharmaceutical preparation | |
| IL300893A (en) | Preparation of modified acrylate compounds | |
| IL303341A (en) | Methods for the preparation of 5-bromo-2-(3-chloro-pyridin-2-yl)-2h-pyrazole-3-carboxylic acid |